William C. Stewart

5.3k total citations
184 papers, 3.9k citations indexed

About

William C. Stewart is a scholar working on Ophthalmology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William C. Stewart has authored 184 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Ophthalmology, 37 papers in Pathology and Forensic Medicine and 37 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William C. Stewart's work include Glaucoma and retinal disorders (109 papers), Retinal Diseases and Treatments (48 papers) and Ophthalmology and Eye Disorders (35 papers). William C. Stewart is often cited by papers focused on Glaucoma and retinal disorders (109 papers), Retinal Diseases and Treatments (48 papers) and Ophthalmology and Eye Disorders (35 papers). William C. Stewart collaborates with scholars based in United States, Greece and China. William C. Stewart's co-authors include Anastasios G. P. Konstas, Hugh L. Hennis, M. Bruce Shields, Hurshell H. Hunt, Jacqueline M. Stephens, Jessica N. Jenkins, M. Bruce Shields, Gopalan Sethuraman, Jessica N. Leech and A. G. P. Konstas and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

William C. Stewart

173 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William C. Stewart United States 31 2.4k 1.3k 835 532 517 184 3.9k
David Miller United States 25 2.2k 0.9× 1.8k 1.4× 322 0.4× 397 0.7× 148 0.3× 109 3.2k
Carolien Panhuysen United States 28 1.5k 0.6× 869 0.7× 262 0.3× 469 0.9× 171 0.3× 44 5.0k
Liang Xu China 34 3.2k 1.3× 2.7k 2.1× 825 1.0× 1.4k 2.6× 123 0.2× 105 4.5k
Szilárd Kiss United States 39 3.4k 1.4× 2.2k 1.8× 152 0.2× 381 0.7× 76 0.1× 153 4.9k
Malik Y. Kahook United States 44 4.4k 1.8× 2.9k 2.3× 1.2k 1.5× 149 0.3× 466 0.9× 202 5.5k
Marian Ludgate United Kingdom 48 633 0.3× 499 0.4× 208 0.2× 680 1.3× 1.7k 3.4× 175 7.0k
Igor Kaiserman Israel 33 2.1k 0.9× 2.3k 1.8× 974 1.2× 505 0.9× 32 0.1× 165 3.7k
Fred Hendrikse Netherlands 34 3.0k 1.2× 2.3k 1.8× 462 0.6× 628 1.2× 160 0.3× 125 3.8k
E. S. Perkins Mexico 28 1.9k 0.8× 928 0.7× 231 0.3× 435 0.8× 285 0.6× 90 2.8k
Chi‐Chun Lai Taiwan 32 3.1k 1.3× 2.9k 2.3× 251 0.3× 706 1.3× 44 0.1× 287 4.8k

Countries citing papers authored by William C. Stewart

Since Specialization
Citations

This map shows the geographic impact of William C. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Stewart more than expected).

Fields of papers citing papers by William C. Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Stewart. The network helps show where William C. Stewart may publish in the future.

Co-authorship network of co-authors of William C. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Stewart. A scholar is included among the top collaborators of William C. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Stewart. William C. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chenshuang, William C. Stewart, Yilong Teng, et al.. (2025). mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity. ACS Nano. 19(44). 38267–38283.
2.
3.
Stewart, William C., et al.. (2023). BioNetGMMFit: estimating parameters of a BioNetGen model from time-stamped snapshots of single cells. npj Systems Biology and Applications. 9(1). 46–46.
4.
Pathak, Shilpa, William C. Stewart, Christin E. Burd, Mark E. Hester, & David A. Greenberg. (2020). Brd2 haploinsufficiency extends lifespan and healthspan in C57B6/J mice. PLoS ONE. 15(6). e0234910–e0234910. 6 indexed citations
5.
Harder, Olivia, William C. Stewart, Phylip Chen, et al.. (2019). Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats. Journal of The Royal Society Interface. 16(160). 20190389–20190389. 20 indexed citations
6.
Peng, Tan Li, et al.. (2018). Mutations in bacterial genes induce unanticipated changes in the relationship between bacterial pathogens in experimental otitis media. Royal Society Open Science. 5(11). 180810–180810. 3 indexed citations
7.
Pathak, Shilpa, James E. Miller, Emily Morris, William C. Stewart, & David A. Greenberg. (2018). DNA methylation of the BRD2 promoter is associated with juvenile myoclonic epilepsy in Caucasians. Epilepsia. 59(5). 1011–1019. 21 indexed citations
8.
Olander, Kenneth W., et al.. (2009). Relationship Between Visual Field Severity and Response to Fixed Combination Dorzolamide/Timolol or Timolol Alone. Journal of Ocular Pharmacology and Therapeutics. 25(4). 357–364. 1 indexed citations
9.
Zöllner, Sebastian, et al.. (2008). Bayesian EM algorithm for scoring polymorphic deletions from SNP data and application to a common CNV on 8q24. Genetic Epidemiology. 33(4). 357–368. 7 indexed citations
10.
Godfrey, David G., Robert D. Fechtner, Donald L. Budenz, William C. Stewart, & Mark C Jasek. (2008). Increased Prevalence of Ocular Surface Disease Symptoms in Glaucoma Patients Using IOP-Lowering Medications. Investigative Ophthalmology & Visual Science. 49(13). 5335–5335. 1 indexed citations
11.
Konstas, A. G. P., et al.. (2006). 24–Hour Control With the Latanoprost/Timolol Maleate Fixed Combination versus Timolol Maleate. Investigative Ophthalmology & Visual Science. 47(13). 442–442. 1 indexed citations
12.
Konstas, Anastasios G. P., et al.. (2004). Intraocular Pressure and Safety in Glaucoma Patients Switching to Latanoprost/Timolol Maleate Fixed Combination from Mono- and Adjunctive Therapies. Journal of Ocular Pharmacology and Therapeutics. 20(5). 375–382. 15 indexed citations
13.
Bayer, Andreas, et al.. (2004). Two-Year Follow-Up of Latanoprost 0.005% Monotherapy After Changing from Previous Glaucoma Therapies. Journal of Ocular Pharmacology and Therapeutics. 20(6). 470–478. 18 indexed citations
14.
Stewart, William C., Anastasios G. P. Konstas, & Norbert Pfeiffer. (2004). Patient and Ophthalmologist Attitudes Concerning Compliance and Dosing in Glaucoma Treatment. Journal of Ocular Pharmacology and Therapeutics. 20(6). 461–469. 46 indexed citations
15.
Zimmerman, Thom J. & William C. Stewart. (2003). Intraocular Pressure, Safety, and Quality of Life in Glaucoma Patients Switching to Latanoprost from Monotherapy Treatments. Journal of Ocular Pharmacology and Therapeutics. 19(5). 405–415. 30 indexed citations
16.
Small, David S., Andrew Acheampong, Brenda L. Reis, et al.. (2002). Blood Concentrations of Cyclosporin A During Long-Term Treatment With Cyclosporin A Ophthalmic Emulsions in Patients With Moderate to Severe Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics. 18(5). 411–418. 39 indexed citations
17.
Stewart, William C., et al.. (1999). Systemic β-Blockade with Once Daily Betimol™ or Timoptic-XE™. Journal of Ocular Pharmacology and Therapeutics. 15(3). 225–231. 7 indexed citations
18.
Mundorf, Thomas K., et al.. (1998). The Safety and Efficacy of Switching Timolol Maleate 0.5% Solution to Timolol Hemihydrate 0.5% Solution Given Twice Daily. Journal of Ocular Pharmacology and Therapeutics. 14(2). 129–135. 33 indexed citations
19.
Ma, Jian‐xing, et al.. (1997). L-deprenyl Protects Injured Retinal Precursor Cells In Vitro. Journal of Ocular Pharmacology and Therapeutics. 13(5). 479–488. 16 indexed citations
20.
Golnik, Karl C., et al.. (1996). Magnetic Resonance Imaging in Patients with Unexplained Optic Neuropathy. Ophthalmology. 103(3). 515–520. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Miller Breakdown of academic impact, for papers by Carolien Panhuysen Breakdown of academic impact, for papers by Liang Xu Breakdown of academic impact, for papers by Szilárd Kiss Breakdown of academic impact, for papers by Malik Y. Kahook Breakdown of academic impact, for papers by Marian Ludgate Breakdown of academic impact, for papers by Igor Kaiserman Breakdown of academic impact, for papers by Fred Hendrikse Breakdown of academic impact, for papers by E. S. Perkins Breakdown of academic impact, for papers by Chi‐Chun Lai
Rankless by CCL
2026